Emma Stevens

407 total citations
15 papers, 259 citations indexed

About

Emma Stevens is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, Emma Stevens has authored 15 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 7 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Emma Stevens's work include Systemic Lupus Erythematosus Research (10 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Emma Stevens is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Emma Stevens collaborates with scholars based in United States, Canada and Netherlands. Emma Stevens's co-authors include Karen H. Costenbader, Elena Massarotti, Sonali Desai, Michael E. Weinblatt, F. Griffin, Srinivas Emani, Hongshu Guan, Jeffrey A. Sparks, Kazuki Yoshida and May Y. Choi and has published in prestigious journals such as Annals of the Rheumatic Diseases, JACC. Cardiovascular imaging and Journal of the American Heart Association.

In The Last Decade

Emma Stevens

15 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Stevens United States 10 162 100 39 35 32 15 259
Julia Ash United States 9 152 0.9× 82 0.8× 39 1.0× 37 1.1× 16 0.5× 16 317
Evan S. Vista United States 11 201 1.2× 136 1.4× 35 0.9× 10 0.3× 42 1.3× 13 311
Е. Л. Лучихина Russia 8 195 1.2× 58 0.6× 22 0.6× 44 1.3× 25 0.8× 69 288
Samina A. Turk Netherlands 10 187 1.2× 77 0.8× 27 0.7× 13 0.4× 34 1.1× 23 287
T. Víkingsdóttir Iceland 7 116 0.7× 171 1.7× 33 0.8× 13 0.4× 28 0.9× 8 319
Ernesto Cairoli Uruguay 9 144 0.9× 66 0.7× 22 0.6× 15 0.4× 29 0.9× 31 285
Sheldon Wang United States 7 133 0.8× 39 0.4× 35 0.9× 23 0.7× 9 0.3× 10 277
Daniela Sieghart Austria 9 147 0.9× 79 0.8× 24 0.6× 9 0.3× 66 2.1× 21 443
Inês Raposo Portugal 9 63 0.4× 125 1.3× 87 2.2× 21 0.6× 24 0.8× 20 274
Motohiro Oribe Japan 10 185 1.1× 100 1.0× 43 1.1× 16 0.5× 33 1.0× 15 330

Countries citing papers authored by Emma Stevens

Since Specialization
Citations

This map shows the geographic impact of Emma Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Stevens more than expected).

Fields of papers citing papers by Emma Stevens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Stevens. The network helps show where Emma Stevens may publish in the future.

Co-authorship network of co-authors of Emma Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Stevens. A scholar is included among the top collaborators of Emma Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Stevens. Emma Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Choi, May Y., Hongshu Guan, Kazuki Yoshida, et al.. (2024). Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 67. 152468–152468. 12 indexed citations
2.
Marchand, Nathalie, May Y. Choi, Nancy R. Cook, et al.. (2023). Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis. Prostaglandins Leukotrienes and Essential Fatty Acids. 190. 102542–102542. 13 indexed citations
3.
Choi, May Y., Brittany Weber, Emma Stevens, et al.. (2022). Prevalence of ECG testing and characteristics among new hydroxychloroquine and chloroquine users within a multi-center tertiary care center. Rheumatology International. 42(10). 1767–1774. 1 indexed citations
4.
Sasaki, Takanori, Joshua Keegan, Lin Chen, et al.. (2022). Longitudinal Immune Cell Profiling in Patients With Early Systemic Lupus Erythematosus. Arthritis & Rheumatology. 74(11). 1808–1821. 32 indexed citations
5.
Weber, Brittany, Emma Stevens, Camden Bay, et al.. (2021). Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus. Journal of the American Heart Association. 10(13). e018555–e018555. 32 indexed citations
6.
Weber, Brittany, Emma Stevens, Lourdes M. Pérez-Chada, et al.. (2021). Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. JACC. Cardiovascular imaging. 14(11). 2212–2220. 29 indexed citations
7.
Choi, May Y., Jill Hahn, Susan Malspeis, et al.. (2021). Association of a Combination of Healthy Lifestyle Behaviors With Reduced Risk of Incident Systemic Lupus Erythematosus. Arthritis & Rheumatology. 74(2). 274–283. 24 indexed citations
8.
Choi, May Y., Nancy R. Cook, Emma Stevens, et al.. (2021). 1102 Fish oil supplementation and pro-inflammatory and pro-resolving lipid mediators in patients with and without systemic lupus erythematosus. Abstracts. A30.1–A30. 1 indexed citations
9.
Case, Siobhan, Candace H. Feldman, Hongshu Guan, et al.. (2021). Posttraumatic Stress Disorder and Risk of Systemic Lupus Erythematosus Among Medicaid Recipients. Arthritis Care & Research. 75(1). 174–179. 18 indexed citations
10.
Desai, Sonali, et al.. (2020). Improving Quality of Care in Rheumatoid Arthritis Through Mobile Patient-Reported Outcome Measurement: Focus Group Study. JMIR Formative Research. 4(3). e15158–e15158. 2 indexed citations
11.
Cui, Jing, Soumya Raychaudhuri, Elizabeth W. Karlson, et al.. (2020). Interactions Between Genome‐Wide Genetic Factors and Smoking Influencing Risk of Systemic Lupus Erythematosus. Arthritis & Rheumatology. 72(11). 1863–1871. 19 indexed citations
12.
Stevens, Emma, Michael E. Weinblatt, Elena Massarotti, et al.. (2020). Safety of the Zoster Vaccine Recombinant Adjuvanted in Rheumatoid Arthritis and Other Systemic Rheumatic Disease Patients: A Single Center's Experience With 400 Patients. ACR Open Rheumatology. 2(6). 357–361. 45 indexed citations
13.
Desai, Sonali, Cianna Leatherwood, Emma Stevens, et al.. (2019). Treat‐to‐Target Approach in Rheumatoid Arthritis: A Quality Improvement Trial. Arthritis Care & Research. 73(2). 207–214. 9 indexed citations
14.
Speyer, Cameron B., Daniel Li, Hongshu Guan, et al.. (2019). Comparison of an administrative algorithm for SLE disease severity to clinical SLE Disease Activity Index scores. Rheumatology International. 40(2). 257–261. 21 indexed citations
15.
Stevens, Emma, Michael E. Weinblatt, Elena Massarotti, F. Griffin, & Sonali Desai. (2019). FRI0068 SAFETY OF THE ZOSTER RECOMBINANT ADJUVANTED VACCINE IN RHEUMATOID ARTHRITIS PATIENTS: A SINGLE CENTER'S EXPERIENCE WITH 300 PATIENTS. Annals of the Rheumatic Diseases. 78. 695–695. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026